medigraphic.com
ISSN 1561-3062 (Electronic)

2016, Number 3

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2016; 42 (3)

Hereditary angioedema and pregnancy

Suárez GJA, Ojeda BJC, Gutiérrez MM

Language: Spanish
References: 20
Page: 354-360
PDF size: 54.48 Kb.


ABSTRACT

Hereditary angioedema is a rare genetic disease presenting in one out of every 50 000 individuals. The condition is characterized by episodes of subcutaneous and submucosal edema. Hormonal alterations may trigger a crisis and pregnancy affects the number of seizures. Two clinical cases are presented of pregnant women with a personal history of hereditary angioedema who had crises during pregnancy, delivery and puerperium, followed by satisfactory evolution. A review was conducted about the topic.


REFERENCES

  1. Zuraw BL. The pathophysiology of Hereditary Angioedema. WAO Journal. 2010;3:S25-S28.

  2. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1 inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009;15:69-78.

  3. Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104:193-204.

  4. Cicardi M, Zanichelli A. Angioedema due to C1 inhibitor deficiency in 2010. Intern Emerg Med. 2010;5:481-6.

  5. Kaplan A. Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010;126:918-25.

  6. Zuraw BL. Hereditary angioedema: a current state-of-the-art review, IV: shortand long-term treatment of hereditary angioedema: out with the old and in with the new? Ann Allergy Asthma Immunol. 2008;100(Suppl 2):S13-S18.

  7. Szema AM, Paz G, Merriam L. Modern preoperative and intraoperative management of hereditary angioedema. Allergy Asthma Proc. 2009;30:338-42.

  8. Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008;100:153-61.

  9. Banerji A, Sloane D, Sheffer AL. Hereditary angioedema: a current state-oftheart review, V: attenuated androgens for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol. 2008;100(Suppl 2):S19-S22.

  10. Zuraw BL. HAE therapies: past present and future. Allergy Asthma Clin Immunol. 2010;6:23-30.

  11. Bernstein JA. Hereditary angioedema: a current state-of-the-art review, VII: current status of emerging therapies. Ann Allergy Asthma Immunol. 2008;100(Suppl 2):S41-S46.

  12. Frank M. Recombinant and plasma-purified human C1 inhibitor for the treatment of hereditary angioedema. WAO Journal. 2010;3:S29-S33.

  13. Christiansen SC, Zuraw BL. Update on therapeutic developments for hereditary angioedema. Allergy Asthma Proc. 2009;30:500-5.

  14. Banerji A. Current treatment of hereditary angioedema: An update on clinical studies. Allergy Asthma Proc. 2010;31:398-406.

  15. Frank MM. Hereditary angioedema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. Ann Allergy Asthma Immunol. 2008;100(Suppl 2):S23-S29.

  16. Riedl M. Hereditary angioedema therapy: Kallikrein inhibition and bradykinin receptor antagonism. WAO Journal. 2010;3:S34-S38.

  17. Eidelman FJ. Hereditary angioedema: New therapeutic options for a potentially deadly disorder. BMC Blood Disord. 2010;10:3-9.

  18. Bouillet L. Hereditary angioedema in women. Allergy Asthma Clin Immunol. 2010;6:17-20.

  19. Ebo DG, Verweij MM, De Knop KJ. Hereditary angioedema in childhood. Pediatr Drugs. 2010;12:257-68.

  20. Calvo CRA, García López JE, Herrero-Morín JD. Angioedema hereditario en pediatría. Bol Pediatr. 2009;49:16-23.




2020     |     www.medigraphic.com